HU173920B - Sposob selektivnogo otdelenija smesi glemaglutinina i nevraminidazy iz virusa grippa - Google Patents

Sposob selektivnogo otdelenija smesi glemaglutinina i nevraminidazy iz virusa grippa

Info

Publication number
HU173920B
HU173920B HU75SA2736A HUSA002736A HU173920B HU 173920 B HU173920 B HU 173920B HU 75SA2736 A HU75SA2736 A HU 75SA2736A HU SA002736 A HUSA002736 A HU SA002736A HU 173920 B HU173920 B HU 173920B
Authority
HU
Hungary
Prior art keywords
neuraminidase
hemagglutinin
mixture
influenza virus
selective isolation
Prior art date
Application number
HU75SA2736A
Other languages
English (en)
Hungarian (hu)
Inventor
Helmut Bachmayer
Gerhard Schmidt
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of HU173920B publication Critical patent/HU173920B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
HU75SA2736A 1974-01-14 1975-01-13 Sposob selektivnogo otdelenija smesi glemaglutinina i nevraminidazy iz virusa grippa HU173920B (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (de) 1974-01-14 1974-01-14

Publications (1)

Publication Number Publication Date
HU173920B true HU173920B (hu) 1979-09-28

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
HU75SA2736A HU173920B (hu) 1974-01-14 1975-01-13 Sposob selektivnogo otdelenija smesi glemaglutinina i nevraminidazy iz virusa grippa

Country Status (27)

Country Link
JP (2) JPS58407B2 (de)
AT (1) AT345449B (de)
AU (1) AU500250B2 (de)
BE (1) BE824372A (de)
CA (1) CA1049406A (de)
CH (1) CH589453A5 (de)
CS (1) CS191254B2 (de)
DD (1) DD116239A5 (de)
DE (1) DE2500785B2 (de)
DK (1) DK140003B (de)
ES (1) ES433759A1 (de)
FI (1) FI54053C (de)
FR (1) FR2257305B1 (de)
GB (1) GB1498261A (de)
HK (1) HK56380A (de)
HU (1) HU173920B (de)
IE (1) IE40794B1 (de)
IL (1) IL46426A (de)
MY (1) MY8100204A (de)
NL (1) NL166622C (de)
NO (1) NO143128C (de)
PH (1) PH14458A (de)
PL (1) PL93689B1 (de)
SE (1) SE427238B (de)
SU (1) SU616997A3 (de)
YU (1) YU41289B (de)
ZA (1) ZA75259B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
JPH0688911B2 (ja) * 1985-06-06 1994-11-09 国立予防衛生研究所長 インフルエンザワクチン及びその製造方法
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (de) 1997-11-25 1999-06-02 Duphar International Research B.V Impfstoff, dessen Adjuvant aus B-Untereinheiten des hitzelabilen Enterotoxins (LTB) von Escherichiacoli besteht
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
PT2301572E (pt) * 2005-11-01 2014-12-22 Novartis Vaccines & Diagnostic Vacinas virais derivadas de células com níveis baixos de adn celular residual
CN101790381B (zh) * 2007-08-28 2014-08-27 巴克斯特国际公司 生产病毒疫苗的方法
AU2014350370B2 (en) 2013-11-15 2017-04-13 Novartis Ag Removal of residual cell culture impurities

Also Published As

Publication number Publication date
DK140003C (de) 1979-10-29
YU41289B (en) 1987-02-28
GB1498261A (en) 1978-01-18
DD116239A5 (de) 1975-11-12
JPS6035326B2 (ja) 1985-08-14
IE40794L (en) 1975-07-14
NL166622C (nl) 1981-09-15
FI54053B (fi) 1978-06-30
PL93689B1 (de) 1977-06-30
DE2500785C3 (de) 1980-09-11
IE40794B1 (en) 1979-08-15
YU5875A (en) 1984-04-30
IL46426A (en) 1978-01-31
SU616997A3 (ru) 1978-07-25
AU500250B2 (en) 1979-05-17
NO143128C (no) 1980-12-29
PH14458A (en) 1981-07-29
BE824372A (fr) 1975-07-14
NL166622B (nl) 1981-04-15
NL7500301A (nl) 1975-07-16
ATA21475A (de) 1978-01-15
NO750031L (de) 1975-08-11
JPS50100224A (de) 1975-08-08
FI750014A (de) 1975-07-15
NO143128B (no) 1980-09-15
CS191254B2 (en) 1979-06-29
DE2500785A1 (de) 1975-07-31
MY8100204A (en) 1981-12-31
SE427238B (sv) 1983-03-21
IL46426A0 (en) 1975-04-25
HK56380A (en) 1980-10-16
AT345449B (de) 1978-09-11
FR2257305A1 (de) 1975-08-08
FR2257305B1 (de) 1982-03-19
FI54053C (fi) 1978-10-10
ES433759A1 (es) 1977-02-16
DK140003B (da) 1979-06-05
ZA75259B (en) 1976-08-25
DE2500785B2 (de) 1980-01-03
JPS58407B2 (ja) 1983-01-06
CA1049406A (en) 1979-02-27
AU7730575A (en) 1976-07-15
JPS56127319A (en) 1981-10-06
CH589453A5 (de) 1977-07-15
DK1475A (de) 1975-09-01
SE7500130L (de) 1975-07-15

Similar Documents

Publication Publication Date Title
YU37054B (en) Process for the preparation of structured soya
NL161462B (nl) Werkwijze ter bereiding van een farmaceutisch preparaat en werkwijze ter bereiding van daarvoor geschikte verbindingen.
HU173920B (hu) Sposob selektivnogo otdelenija smesi glemaglutinina i nevraminidazy iz virusa grippa
AU526356B2 (en) Amino acid intermediates for the preparation of prosta- glandin analogues
BE809668A (nl) Werkwijze voor de bereiding van een reducerend gas
JPS51133414A (en) Production of vaccine against viral hepatisis
ZA752394B (en) Process for the isolation of gama-l-glutamyl-taurine
HU173548B (hu) Sposob poluchenija rekombinacionnogo shtamma virusa grippa i vakciny soderzhajuhhej ehtot shtamma
BR7500319A (pt) Processo para a preparacao de azocorantes contendo cianogrupos
IT1034411B (it) Processo per la preparazione di un catalizzatore misto
IL48062A (en) Process for the preparation of meta-substituted halogenophenols
CH611518A5 (en) Process for the preparation of a virus subunit vaccine
CH611338A5 (en) Process for the preparation of inactivated HB-Ag vaccines
KE3101A (en) New pharmaceutical compositions and a process for the preparation thereof
ZA753266B (en) New pharmaceutical compositions and a process for the preparation thereof
CH479700A (de) Verfahren zur Gewinnung einer zur Herstellung von Influenzavaccinen geeigneten virushaltigen Allantoisflüssigkeit
PH13148A (en) A process for the preparation of triazapentadienes
PH12704A (en) Influenza vaccine containing a recombinant antigenically hybridized virus and method of using the same
PH13837A (en) Influenza vaccine containing purified neuraminidase antigen and method of using the same
CH609031A5 (en) A process for the preparation of amines
ZA753988B (en) Process for the preparation of a methane-containing gas
IT1028106B (it) Procedimento per la preparazione di alchil secondario ammine primarie da ossime
CH613445A5 (en) Process for the preparation of novel N-(p-fluorobenzoylpropyl)-4-piperidylamides
JPS52156920A (en) Proauction of raw influenza virus vaccine
GB1485916A (en) Process for the preparation of propargyl amines and products obtained thereby

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee